SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 24, 2026

KRRO

Korro Bio, Inc.
BEARISH
Impact 6/10
Horizondays Processed4mo ago
Insider cluster: 5 insiders, $0.2M total
Actionable Insight ▼ Bearish

Monitor for any upcoming corporate events or news that may have prompted the selling. The concentration of sales by a director is notable and could signal negative sentiment ahead of a catalyst. Watch for further insider activity or a material adverse event.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
KRRO ▼ -17.67% at T+60d
SHORT call ✓ call won +17.67% · α vs SPY +21.40% · entry $12.17 → $10.02
Entry = T+0 close
Jun 24, 2026
via day close
T+1d
+4.36%
call -4.36% · α -5.08%
$12.70
settled 4mo ago
T+5d
+12.16%
call -12.16% · α -10.60%
$13.65
settled 4mo ago
T+20d
-5.26%
call +5.26% · α +5.79%
$11.53
settled 3mo ago
T+60d
-17.67%
call +17.67% · α +21.40%
$10.02
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Multiple insiders at Korro Bio sold shares totaling $2.3M over a 10-day window, led by director Jean Francois Formela who sold $2.09M. The sales represent 1.2% of market cap, a material amount. While officer sales were small, the director's large sale raises caution.

Key Financial Metrics

Direction
selling
Total Value
$2.3M
Insiders
5

Key Facts

  • Director Jean Francois Formela sold 145,640 shares for $2.09M across three days (June 22-24).
  • COO Todd Chappell sold 3,200 shares for $34K on June 16.
  • General Counsel Jeffrey Cerio sold 6,600 shares for $72K on June 16.
  • SVP Finance Oliver Dolan sold 3,400 shares for $37K on June 16.
  • CSO Loic Vincent sold 3,400 shares for $37K on June 16.
  • Total insider sales of $2.3M represent ~1.2% of KRRO's $198M market cap.

Financial Impact

Total insider sales of $2.3M, approximately 1.2% of market cap.

dilutionmarket cap

Risk Factors

  • Potential negative corporate news or clinical trial setback.
  • Further insider selling could pressure the stock.
  • Director's large sale may indicate loss of confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KRRO-1782346170882
20 reports for KRRO
Performance horizon
83% Hit rate @ T+1 5 of 6 directional calls Went positive at some point 5 of 6 best @ T+5▲ +50.38%May 19, 2026
Filters
Rows
Reports for KRRO — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 2/10
$12.73awaiting T+1—$13.30 (+4.48%)
Oct 26, 2026
1d ago
Insider Buy
BULLISH ★ 5/10
$12.46awaiting T+1—$13.30 (+6.74%)
Oct 22, 2026
5d ago
8-K
BULLISH ★ 6/10
$12.05 $11.98▼ −0.58%▼ −0.06%$13.30 (+10.37%)
Oct 16, 2026
11d ago
Press Release
NEUTRAL ★ 2/10
$8.91 $9.44▲ +5.95%▲ +5.61%$13.30 (+49.27%)
Oct 5, 2026
22d ago
8-K
NEUTRAL ★ 4/10
$9.76 $10.49▲ +7.48%▲ +7.72%$13.30 (+36.27%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 4/10
$9.76 $10.49▲ +7.48%▲ +7.72%$13.30 (+36.27%)
Sep 15, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$13.83 $11.80▼ −14.68%▼ −15.81%$13.30 (−3.83%)
Aug 13, 2026
10w ago
Insider Cluster
NEUTRAL ★ 4/10
$13.29 $13.28▼ −0.08%▲ +0.12%$13.30 (+0.08%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 6/10
$12.12 $13.25▲ +9.32%▲ +8.71%$13.30 (+9.74%)
Jul 9, 2026
15w ago
Institutional Cluster
BULLISH ★ 6/10
$14.30 $14.56▲ +1.82%▲ +1.39%$13.30 (−6.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 24, 2026